Picture of IRIDEX logo

IRIX — IRIDEX News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Iridex Corp Reports Results For The Quarter Ended In March: Earnings Summary

* IRIDEX Corp  IRIX.OQ  reported a quarterly adjusted loss
of 13
cents​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 12
cents per share.
    * Revenue rose 2.4% to $13.71 million from a year ago;
analysts
expected $13.64 million. 
    * IRIDEX Corp's reported EPS for the quarter was a loss
of 13
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * IRIDEX Corp shares had risen by 11.8% this quarter and
gained 12.9% so far this year.
    * The company reported a quarterly loss of $2.09 million.
    * Wall Street's median 12-month price target for IRIDEX Corp
is
$4.63 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 09:56 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.12          -0.13          Missed
 Dec. 31 2022      -0.11          -0.07          Beat
 Sep. 30 2022      -0.14          -0.11          Beat
 Jun. 30 2022      -0.15          -0.14          Beat

Recent news on IRIDEX

See all news